Keith Speights
Keith Speights has been a contributing writer and analyst for The Motley Fool since 2012. Prior to The Motley Fool, Speights was CEO of a healthcare technology company; vice president of a healthcare software company; director of operations for a health insurer; and a technology consultant. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights
Should You Buy Amazon Stock in 2025?
3 No-Brainer Stocks to Buy on the Latest Sell-Off
3 Stocks That Could Turn $1,000 into $5,000 by 2030
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
HOW THE MOTLEY FOOL CAN HELP YOU
-
Premium Investing Guidance
Market beating stocks from our award-winning service
-
The Daily Upside Newsletter
Investment news and high-quality insights delivered straight to your inbox
-
Get Started Investing
You can do it. Successful investing in just a few steps
-
Win at Retirement
Secrets and strategies for the post-work life you want.
-
Find a Broker
Find the right brokerage account for you.
-
Listen to our Podcasts
Hear our experts take on stocks, the market, and how to invest.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.